METRN Antibody targets the Meteorin protein encoded by the METRN gene (NCBI Gene ID: 79006). Meteorin regulates glial cell differentiation and promotes axonal extension in sensory neurons, making it vital for nervous system development . The antibody enables researchers to visualize METRN expression and study its mechanisms in vitro and in vivo.
METRN shares paralogs like METRNL (Meteorin-like), which has distinct roles in immune regulation .
METRN Antibody (e.g., Aviva Systems Biology’s OACD05531) is validated for multiple applications :
| Application | Protocol Details |
|---|---|
| Western Blot (WB) | Dilution: 0.5–3 µg/mL; detects METRN at ~30 kDa (observed MW may vary) |
| Immunohistochemistry | Dilution: 5–30 µg/mL; localizes METRN in tissue sections |
| Immunocytochemistry | Dilution: 5–30 µg/mL; visualizes METRN in cultured cells |
Host Species: Rabbit
Clonality: Polyclonal
Reactivities: Mouse, Rat (predicted)
Immunogen: Recombinant METRN (Gly22–Asp291)
Neurogenesis: METRN induces astrocyte differentiation and converts cerebellar astrocytes into radial glia, critical for neural circuit formation .
Disease Links: METRN dysregulation is associated with Charcot-Marie-Tooth Disease Type 4, highlighting its potential as a therapeutic target .
Mechanistic Insights: Studies using METRN Antibody have revealed its role in activating satellite glia to promote axonal growth in sensory neurons .
While METRN itself is distinct from the MET proto-oncogene (a receptor tyrosine kinase) , research tools like METRN Antibody help disentangle its unique functions. For example: